Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DOI

10.1093/eurheartj/ehz425

Type

Journal article

Journal

Eur Heart J

Publication Date

14/01/2020

Volume

41

Pages

407 - 477

Keywords

Guidelines, angina pectoris, anti-ischaemic drugs, antithrombotic therapy, chronic coronary syndromes, coronary artery disease, diagnostic testing, imaging, lifestyle modifications, lipid-lowering drugs, microvascular angina, myocardial ischaemia, myocardial revascularization, risk assessment, screening, vasospastic angina, Cardiology, Chronic Disease, Coronary Artery Disease, Diagnostic Techniques, Cardiovascular, Disease Management, Europe, Humans, Societies, Medical, Syndrome